User Research
User Testing
Redesign
Prototyping
Data Tables
Heuristic Analysis
Dosing App - Oncology
Enabling a one-stop-shop for dosing and adverse events information for various BMS oncology products
Date
May - September 2024
Role
UX Designer
Teams
Brand Management, EU Markets, Senior Medical Advisory
Overview
Lack of Centralized Dosing Resource Complicated Dosing of BMS Oncology Products
BMS owns multiple drugs and medications across various world markets. Dosing guidelines vary between them but there is no standard resource. Dosages also vary between products depending on therapeutic area, indication, market regulations and patient information. Our goal therefore is to design a web-based application for healthcare professionals (HCPs) to easily look up dosage guidance. After success with CAMZYOS in the cardiology therapeutic area, Oncology was interested in onboarding their products into the Dosing App.
There was an Austrian market based app, but it is oriented just to one market, lacks accessibility and is not regularly updated. It also relied on images with dosing data that does not translate languages after translating the browser. Doctors and Nurses relied on this, PDFs, and PowerPoints for dosage.
Process
Challenge: Translating a new type of dosage - as well as a complex side effects management flow- for oncology drugs and conditions into an intuitive webapp
Lasting about half a year, this engagement conducted regular checkpoints with our stakeholders and ended with a readout. This engagement was also concurrent with other projects. The first CAMZYOS dosing app laid a lot of groundwork.
This cycle was done for both the dosing and Adverse Events (side effects) flows.
01
Discover
We had to understand how the IO products' dosage worked - although it is much simpler than CAMZYOS, there are various combinations of products and phases that depend on market. Adverse Events is also much more complicated because it depends on product and TA. The goal was to redesign crucial unique components (like the dosage timelines) and recognize patterns that can be customized by content (Adverse Events components). The assets used to design is the Austrian app, a competitive analysis we had made for CAMZYOS, PowerPoints and of course our stakeholders' knowledge!
02
Redesign
The dosage timelines had to be altered to fit multiple products, chemo and other adjustments for the indications in scope
Adverse Events flow and content had to be altered as well
BMS Plus (From where the app would be entered in the Swiss market) had to have a page designed to include all the indications and products
Checkpoints with accessibility managers
Mobile versions of dosage and AE
03
Approval
Approval of designs worked in segments. Approval was given from medical personnel, publishing team as well as other SMEs.
The oncology product website provides dosing guidelines but users would have to flip through about 30 pages to switch between stages. Users also cannot input patient type, therapeutic area and indication at once to see treatment plan.
Initial competative analysis
This was the CAMZYOS dosing iPDF which we initially translated to a webapp. This informed the information architecture of the oncology products as well.
Outcome
A new line of oncology products for the BMS Dosing App!
Healthcare providers are closer to having a single dosing repository for all applicable products.
Expansion of Dosage App
The new Therapeutic Area of Oncology has been formatted for the dosage app within the Swiss market! Therefore, it can be expanded to new markets and indications, barring situations requiring new design.
Reduced Developmental Risk
Designing the crucial dosage timelines (Static Dosages) as well as a UI kit, facilitated development work reducing the need of building it out from scratch. Having the flow mapped out also helped in building out the architecture of the app.
Broadened Accessibility
Many accessibility issues are present on the Austrian app such as images with non-scannable dosage measurements or alt text. The dosage and adverse events are designed to be keyboard navigable as well as adhere to a semantic structure, etc.
Design
Some components from CAMZYOS were leveraged, core dosage elements were modified
This is but another product added onto an already designed and shipped dosing app. The top menu can expand to to change parameters and buttons and text format were carried over as well. The dosing however had to be modified and timeline design had to indicate repeated dosage over time, pauses etc.
How does Adverse Events (side effects) Work?
Users (usually healthcare professionals) can enter the drug combination, type of AE and category. They then see the adverse events separated by category. The mockup shows all the accordion windows open but they will be closed by default.
When clicking the AE tab from dosage, it will be auto-updated with the same drug and the user will choose the AE. The AE's hinge on product and not therapeutic area or indication.
Users would also be able to report the AE below.
Stakeholder Quote
Stakeholder Quote
"I believe that the team’s alignment, combined with Arka’s extremely valuable experience and insights, enabled us to achieve best-in-class UI app design, positively impacting the business. We have taken a careful approach to ensure accessibility and streamline adoption, allowing this build to be easily embraced across all markets and supporting a successful global rollout"
Senior Manager (European Markets and ICON)
One of the most impactful things from this engagement was that:
An uninsured Norwegian patient was able to be prescribed for his cancer
This was communicated by a senior medical advisor.